Zenlabs Ethica Limited, established in 1993, is a prominent Indian pharmaceutical contract marketing and trading company. It ranks among the top ten in the industry, offering an extensive portfolio of over 600 products across various therapeutic segments, including Gastrointestinal, Anti-Diabetics, Anti-Hypertensive, Anti-Infective, and Nutraceuticals. The company, previously known as Neelkanth Technologies Limited, collaborates with Zenlabs Pharmaceutical Inc, Canada, to maintain a global network for marketing and distribution.
In 2023, Zenlabs Ethica expanded into Neurology and Cytrics, adhering to international standards and maintaining WHO GMP certification. This ensures advanced quality in procurement and supply, with products marketed in factory packaging. With a focus on quality and affordability, Zenlabs Ethica continues to enhance health care, making it a leader in the Indian pharmaceutical sector.
